Vivozon Healthcare Inc Cash Flow-to-Debt Ratio
Vivozon Healthcare Inc cash flow-to-debt ratio. Vivozon Healthcare Inc (082800) has a Cash Flow-to-Debt Ratio of -0.02x as of June 2026, meaning its operating cash flow of ₩-1.10 Billion could theoretically repay 0% of its total liabilities (₩68.23 Billion) in one year. Check 082800 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Vivozon Healthcare Inc (2014–2025)
Cash flow-to-debt ratio of Vivozon Healthcare Inc from 2014 to 2025. Historical debt coverage capacity for Vivozon Healthcare Inc across 12 annual periods. Check Vivozon Healthcare Inc (082800) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Vivozon Healthcare Inc Cash Flow-to-Debt Ratio by Year (2014–2025)
Vivozon Healthcare Inc cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for Vivozon Healthcare Inc. For the full cash flow conversion analysis, see 082800 cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.07x | ₩-6.87 Billion | ₩92.82 Billion | ▼ -200.7% |
| 2024 | 0.07x | ₩5.73 Billion | ₩78.02 Billion | ▲ +70.8% |
| 2023 | 0.04x | ₩2.99 Billion | ₩69.58 Billion | ▲ +205.1% |
| 2022 | -0.04x | ₩-3.32 Billion | ₩81.24 Billion | ▲ +74.4% |
| 2021 | -0.16x | ₩-17.50 Billion | ₩109.35 Billion | ▼ -585.6% |
| 2020 | 0.03x | ₩4.62 Billion | ₩140.36 Billion | ▲ +147.1% |
| 2019 | -0.07x | ₩-3.89 Billion | ₩55.66 Billion | ▲ +50.9% |
| 2018 | -0.14x | ₩-4.59 Billion | ₩32.21 Billion | ▲ +37.0% |
| 2017 | -0.23x | ₩-4.59 Billion | ₩20.31 Billion | ▼ -174.0% |
| 2016 | 0.31x | ₩5.87 Billion | ₩19.22 Billion | ▲ +163.8% |
| 2015 | 0.12x | ₩2.78 Billion | ₩24.05 Billion | ▼ -24.9% |
| 2014 | 0.15x | ₩3.03 Billion | ₩19.64 Billion | — |